Profound Muscle Weakness and Pain after One Dose of Actonel

The World Health Organization (WHO) defines osteopenia as a bone density between 1 and 2.5 standard deviation (SD) below the bone density of a normal young adult Iqbal 2000. Osteoporosis is defined as 2.5 SD or more below that reference point Iqbal 2000. Bisphosphonates are a group of medications us...

Descripción completa

Detalles Bibliográficos
Autores principales: Badayan, Irina, Cudkowicz, Merit E.
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2009
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2760234/
https://www.ncbi.nlm.nih.gov/pubmed/19826634
http://dx.doi.org/10.1155/2009/693014
_version_ 1782172729935396864
author Badayan, Irina
Cudkowicz, Merit E.
author_facet Badayan, Irina
Cudkowicz, Merit E.
author_sort Badayan, Irina
collection PubMed
description The World Health Organization (WHO) defines osteopenia as a bone density between 1 and 2.5 standard deviation (SD) below the bone density of a normal young adult Iqbal 2000. Osteoporosis is defined as 2.5 SD or more below that reference point Iqbal 2000. Bisphosphonates are a group of medications used to treat osteoporosis, Padget's disease of bone, and osteopenia. We report a woman who developed profound muscle weakness and pain after one dose of Risedronate (Actonel).
format Text
id pubmed-2760234
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-27602342009-10-13 Profound Muscle Weakness and Pain after One Dose of Actonel Badayan, Irina Cudkowicz, Merit E. Case Rep Med Case Report The World Health Organization (WHO) defines osteopenia as a bone density between 1 and 2.5 standard deviation (SD) below the bone density of a normal young adult Iqbal 2000. Osteoporosis is defined as 2.5 SD or more below that reference point Iqbal 2000. Bisphosphonates are a group of medications used to treat osteoporosis, Padget's disease of bone, and osteopenia. We report a woman who developed profound muscle weakness and pain after one dose of Risedronate (Actonel). Hindawi Publishing Corporation 2009 2009-10-11 /pmc/articles/PMC2760234/ /pubmed/19826634 http://dx.doi.org/10.1155/2009/693014 Text en Copyright © 2009 I. Badayan and M. E. Cudkowicz. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Badayan, Irina
Cudkowicz, Merit E.
Profound Muscle Weakness and Pain after One Dose of Actonel
title Profound Muscle Weakness and Pain after One Dose of Actonel
title_full Profound Muscle Weakness and Pain after One Dose of Actonel
title_fullStr Profound Muscle Weakness and Pain after One Dose of Actonel
title_full_unstemmed Profound Muscle Weakness and Pain after One Dose of Actonel
title_short Profound Muscle Weakness and Pain after One Dose of Actonel
title_sort profound muscle weakness and pain after one dose of actonel
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2760234/
https://www.ncbi.nlm.nih.gov/pubmed/19826634
http://dx.doi.org/10.1155/2009/693014
work_keys_str_mv AT badayanirina profoundmuscleweaknessandpainafteronedoseofactonel
AT cudkowiczmerite profoundmuscleweaknessandpainafteronedoseofactonel

Ejemplares similares